TABLE 1.
Patient Characteristics
| Characteristics | Control Patients (n = 16) | Active UC (n = 14) | UC in Remission (n = 14) |
|---|---|---|---|
| Gender (male/female) | 11/5 | 9/5 | 9/5 |
| Age, y, mean ± SD | 52.9 ± 16.9 | 40.7 ± 13.9 | 46.5 ± 16.0 |
| Clinical score ± SD | 0 | 7.78 ± 1.52 | 0.44 ± 1.01* |
| Endoscopy score mean ± SD | 0 | 1.79 ± 0.43 | 0 |
| Geboes score (total) | n.d. | 6.53 ± 2.93 | 1.07 ± 1.73 |
| TNF-α copies/µg RNA ± SD | 3,663 ± 1,973 | 15,907 ± 9,623 | 4,645 ± 1,830 |
| Calprotectin (mg/kg) mean ± SD | n.d. | 587.5 ± 483.8† | 53.9 ± 41.1 |
| Extension of disease‡ | _ | 2/9/3 | 2/8/4 |
| Medication§ | _ | _ | 14/4/5 |
aAverage score of 9 patients.
†Average calprotectin levels in 11 patients.
‡Proctitis/left-sided colitis/pancolitis.
§5-aminosalicylic acids/steroids/immunosuppressives.
n.d. indicates not determined; TNF-α, tumor necrosis factor-alpha.